Related references
Note: Only part of the references are listed.Clinical Review on the Management of Metastatic Renal Cell Carcinoma
Jennifer Tran et al.
JCO ONCOLOGY PRACTICE (2022)
Translocation carcinomas of the kidney
Pedram Argani
GENES CHROMOSOMES & CANCER (2022)
Intracranial and extracranial efficacy of lorlatinib in patients with ALK-positive non-small-cell lung cancer previously treated with second-generation ALK TKIs
E. Felip et al.
ANNALS OF ONCOLOGY (2021)
Prospective Multicenter Validation of the Detection of ALK Rearrangements of Circulating Tumor Cells for Noninvasive Longitudinal Management of Patients With Advanced NSCLC
Marius Ilie et al.
JOURNAL OF THORACIC ONCOLOGY (2021)
A comparison of sunitinib with cabozantinib, crizotinib, and savolitinib for treatment of advanced papillary renal cell carcinoma: a randomised, open-label, phase 2 trial
Sumanta K. Pal et al.
LANCET (2021)
Novel, emerging and provisional renal entities: The Genitourinary Pathology Society (GUPS) update on renal neoplasia
Kiril Trpkov et al.
MODERN PATHOLOGY (2021)
Towards a new WHO classification of renal cell tumor: what the clinician needs to know-a narrative review
Alessia Cimadamore et al.
TRANSLATIONAL ANDROLOGY AND UROLOGY (2021)
Non-clear cell renal carcinomas: Review of new molecular insights and recent clinical data
Philippe Barthelemy et al.
CANCER TREATMENT REVIEWS (2021)
Tumour-agnostic therapies
Ann-Marie Looney et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
Identification of anaplastic lymphoma kinase fusions in clear cell renal cell carcinoma
Wei Chen et al.
ONCOLOGY REPORTS (2020)
ALK-rearranged renal cell carcinoma with a novel PLEKHA7-ALK translocation and metanephric adenoma-like morphology
Jen-Fan Hang et al.
VIRCHOWS ARCHIV (2020)
ESC, ALK, HOT and LOT: Three Letter Acronyms of Emerging Renal Entities Knocking on the Door of the WHO Classification
Farshid Siadat et al.
CANCERS (2020)
Report From the International Society of Urological Pathology (ISUP) Consultation Conference on Molecular Pathology of Urogenital Cancers
Sean R. Williamson et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2020)
ALK rearranged renal cell carcinoma (ALK-RCC): a multi-institutional study of twelve cases with identification of novel partner genes CLIP1, KIF5B and KIAA1217
Naoto Kuroda et al.
MODERN PATHOLOGY (2020)
Targetable gene fusions and aberrations in genitourinary oncology
Filippo Pederzoli et al.
NATURE REVIEWS UROLOGY (2020)
ALK rearrangement in TFE3-positive renal cell carcinoma: Alternative diagnostic option to exclude Xp11.2 translocation carcinoma
Yiqi Zhu et al.
PATHOLOGY RESEARCH AND PRACTICE (2020)
Anaplastic lymphoma kinase (ALK) rearrangement in adult renal cell carcinoma with lung metastasis: a case report and literature review
Shengyu Zhou et al.
TRANSLATIONAL ANDROLOGY AND UROLOGY (2020)
The Emerging Therapeutic Landscape of ALK Inhibitors in Non-Small Cell Lung Cancer
Valerio Gristina et al.
PHARMACEUTICALS (2020)
Nivolumab plus ipilimumab versus sunitinib for first-line treatment of advanced renal cell carcinoma: extended 4-year follow-up of the phase III CheckMate 214 trial
Laurence Albiges et al.
ESMO OPEN (2020)
Characteristics of Renal Cell Carcinoma Harboring TPM3-ALK Fusion
Chang Gok Woo et al.
YONSEI MEDICAL JOURNAL (2020)
A Phase Ib Study of Axitinib in Combination with Crizotinib in Patients with Metastatic Renal Cell Cancer or Other Advanced Solid Tumors
M. Dror Michaelso et al.
ONCOLOGIST (2019)
ALK-rearranged renal cell carcinomas in Polish population
Adam Gorczynski et al.
PATHOLOGY RESEARCH AND PRACTICE (2019)
ALK-TPM3 rearrangement in adult renal cell carcinoma: a case report and literature review
Jing Yang et al.
DIAGNOSTIC PATHOLOGY (2019)
Anaplastic lymphoma kinase fusions: Roles in cancer and therapeutic perspectives
Zhifa Cao et al.
ONCOLOGY LETTERS (2019)
Responses to Alectinib in ALK-rearranged Papillary Renal Cell Carcinoma
Sumanta K. Pal et al.
EUROPEAN UROLOGY (2018)
ALK-TPM3 rearrangement in adult renal cell carcinoma: Report of a new case showing loss of chromosome 3 and literature review
Yohan Bodokh et al.
CANCER GENETICS (2018)
ALK Fusions in Renal Cell Carcinoma: Response to Entrectinib
Jessica J. Tao et al.
JCO PRECISION ONCOLOGY (2018)
Methodological quality and synthesis of case series and case reports
Mohammad Hassan Murad et al.
BMJ EVIDENCE-BASED MEDICINE (2018)
A REVIEW OF ALK-REARRANGED RENAL CELL CARCINOMAS WITH A FOCUS ON CLINICAL AND PATHOBIOLOGICAL ASPECTS
Naoto Kuroda et al.
POLISH JOURNAL OF PATHOLOGY (2018)
Crizotinib achieves long-lasting disease control in advanced papillary renal-cell carcinoma type 1 patients with MET mutations or amplification. EORTC 90101 CREATE trial
Patrick Schoffski et al.
EUROPEAN JOURNAL OF CANCER (2017)
Genetic analysis and clinicopathological features of ALK-rearranged renal cell carcinoma in a large series of resected Chinese renal cell carcinoma patients and literature review
Wenjuan Yu et al.
HISTOPATHOLOGY (2017)
ALK-Testing in non-small cell lung cancer (NSCLC): Immunohistochemistry (IHC) and/or fluorescence in-situ Hybridisation (FISH)? Statement of the Germany Society for Pathology (DGP) and the Working Group Thoracic Oncology (AIO) of the German Cancer Society e.V. (Stellungnahme der Deutschen Gesellschaft fur Pathologie und der AG Thorakale Onkologie der Arbeitsgemeinschaft Onkologie/Deutsche Krebsgesellschaft e.V.)
M. von Laffert et al.
LUNG CANCER (2017)
ALK Fusions in a Wide Variety of Tumor Types Respond to Anti-ALK Targeted Therapy
Jeffrey S. Ross et al.
ONCOLOGIST (2017)
A case of anaplastic lymphoma kinase-positive renal cell carcinoma coincident with Hodgkin lymphoma
Yuzo Oyama et al.
PATHOLOGY INTERNATIONAL (2017)
Homogeneity and High Concordance of ALK Translocation in Primary Lung Adenocarcinoma and Paired Lymph Node Metastasis
Wei Ma et al.
SCIENTIFIC REPORTS (2017)
Two Cases of Renal Cell Carcinoma Harboring a Novel STRN-ALK Fusion Gene
Hironori Kusano et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2016)
The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours
Holger Moch et al.
EUROPEAN UROLOGY (2016)
Expanding the Spectrum of ALK-Rearranged Renal Cell Carcinomas in Children: Identification of a Novel HOOK1-ALK Fusion Transcript
Mariana M. Cajaiba et al.
GENES CHROMOSOMES & CANCER (2016)
ALK-rearranged renal cell carcinomas in children
Mariana M. Cajaiba et al.
GENES CHROMOSOMES & CANCER (2016)
TFE3-positive renal cell carcinomas are not always Xp11 translocation carcinomas: Report of a case with a TPM3-ALK translocation
Paul Scott Thorner et al.
PATHOLOGY RESEARCH AND PRACTICE (2016)
ALK rearrangements-associated renal cell carcinoma (RCC) with unique pathological features in an adult
Marie Jeanneau et al.
PATHOLOGY RESEARCH AND PRACTICE (2016)
Molecular analysis of aggressive renal cell carcinoma with unclassified histology reveals distinct subsets
Ying-Bei Chen et al.
NATURE COMMUNICATIONS (2016)
High concordance of ALK rearrangement between primary tumor and paired metastatic lymph node in patients with lung adenocarcinoma
Likun Hou et al.
JOURNAL OF THORACIC DISEASE (2016)
Combination Strategy Targeting VEGF and HGF/c-met in Human Renal Cell Carcinoma Models
Eric Ciamporcero et al.
MOLECULAR CANCER THERAPEUTICS (2015)
VCL-ALK Renal Cell Carcinoma in Children With Sickle-cell Trait The Eighth Sickle-cell Nephropathy?
Nathaniel E. Smith et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2014)
MET Is a Potential Target across All Papillary Renal Cell Carcinomas: Result from a Large Molecular Study of pRCC with CGH Array and Matching Gene Expression Array
Laurence Albiges et al.
CLINICAL CANCER RESEARCH (2014)
ALK-positive cancer: still a growing entity
Adam Gorczynski et al.
FUTURE ONCOLOGY (2014)
Increased ALK1 copy number and renal cell carcinoma-a case report
Ciara Ryan et al.
VIRCHOWS ARCHIV (2014)
ALK-Positive Renal Cell Carcinoma in a Large Series of Consecutively Resected Korean Renal Cell Carcinoma Patients
Cheol Lee et al.
KOREAN JOURNAL OF PATHOLOGY (2013)
ALK alterations in adult renal cell carcinoma: frequency, clinicopathologic features and outcome in a large series of consecutively treated patients
William R. Sukov et al.
MODERN PATHOLOGY (2012)
Treating ALK-positive lung cancer-early successes and future challenges
D. Ross Camidge et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2012)
ALK Rearrangement in Sickle Cell Trait-Associated Renal Medullary Carcinoma
Adrian Marino-Enriquez et al.
GENES CHROMOSOMES & CANCER (2011)
Renal cell carcinoma with novel VCL-ALK fusion: new representative of ALK-associated tumor spectrum
Larisa V. Debelenko et al.
MODERN PATHOLOGY (2011)
Nucleophosmin-anaplastic lymphoma kinase associated with anaplastic large-cell lymphoma activates the phosphatidylinositol 3-kinase/Akt antiapoptotic signaling pathway
RY Bai et al.
BLOOD (2000)
Share Paper
